Study to measure the effectiveness of the Budesonide/formoterol electronic multidose dry powder inhaler (BF Digihaler) Digital System (DS)

- Asthma
- Terminated

Study Title: CONNected Electronic Inhalers Asthma Control Trial 3 ("CONNECT 3"), a 24-Week Treatment, Multicenter, Open Label, Randomized, Parallel Group Comparison Study of Standard of Care Treatment Versus the Budesonide/Formoterol Digihaler Digital System, to Optimize Outcomes in Adult Patients with Asthma

Teva Identifier: BFS-AS-40184

ClinicalTrials.gov Identifier: N/A

Study Status: Terminated

Trial Condition(s): Asthma

Interventions: Drug: Budesonide/Formoterol Digihaler Digital System

EudraCT Number: 2021-003951-41

Study Description

The primary objective of this study is to demonstrate the effectiveness of the Digital System (DS) compared to the Standard of Care group

Print

EudraCT

Key Participation Requirements

Gender: Female, Male

Age group: Adult, Older Adult

Age Range: 18 Years and older

Trial Duration: January 23, 2023 - June 29, 2023

Phase: Phase 4

Plain Language Summary

Study Type

Interventional